Six Unproven Peptides Hit Pharmacy Shelves as FDA Looks Away

An HHS policy effective Oct. 29, 2026 lets compounding pharmacies sell six unapproved peptides, including the 'Wolverine stack,' with no regulator checking safety or ingredients.